Concepedia

Publication | Open Access

The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study

DOIFull Paper Access

93

Citations

32

References

2015

Year

Dongfeng Gu, Jiang He, Pamela G. Coxson, Petra W. Rasmussen, Chen Huang, Anusorn Thanataveerat, Keane Y. Tzong, Juyang Xiong, Miao Wang, Dong Zhao,
PLoS Medicine

Abstract

Expanded hypertension treatment has the potential to prevent about 800,000 cardiovascular disease events annually and be borderline cost-effective in China, provided low-cost essential antihypertensive medicines programs can be implemented.

References

YearCitations

Page 1